Literature DB >> 14745709

CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines.

Yoshinori Ito1, Jean-Charles Grivel, Silvia Chen, Yana Kiselyeva, Patricia Reichelderfer, Leonid Margolis.   

Abstract

In infected individuals, human immunodeficiency virus type 1 (HIV-1) exist as a "swarm" of quasi species compartmentalized in tissues where individual viral variants may interact locally. We have used human lymphoid tissue, where the critical events of HIV disease occur, to study local interactions in model HIV-1 binary swarms ex vivo. We infected tissue blocks with binary mixtures consisting either of CCR5-dependent and CXCR4-dependent variants or of 2 dual-tropic HIV-1 variants, of which one is skewed to utilization of CXCR4 and the other of CCR5. HIV-1 variants that use CXCR4 suppress replication of CCR5-dependent HIV-1 variants, whereas CCR5-dependent HIV-1 variants do not affect replication of CXCR4-dependent HIV-1. CC-chemokines that inhibit replication of CCR5-dependent HIV-1 variants were up-regulated by CXCR4-dependent HIV-1, thus possibly contributing to this suppression. Tissue-specific chemokine/cytokine network modulations triggered by individual HIV-1 variants may be an important mechanism of local interactions among HIV-1 quasi species in infected tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745709     DOI: 10.1086/381153

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.

Authors:  Guity Ghaffari; Daniel L Tuttle; Daniel Briggs; Brant R Burkhardt; Deepa Bhatt; Warren A Andiman; John W Sleasman; Maureen M Goodenow
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.

Authors:  Andrea Lisco; Jean-Charles Grivel; Angélique Biancotto; Christophe Vanpouille; Francesco Origgi; Mauro S Malnati; Dominique Schols; Paolo Lusso; Leonid B Margolis
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

Review 3.  Coinfecting viruses as determinants of HIV disease.

Authors:  Andrea Lisco; Christophe Vanpouille; Leonid Margolis
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

4.  Contrasting roles for TLR ligands in HIV-1 pathogenesis.

Authors:  Beda Brichacek; Christophe Vanpouille; Yana Kiselyeva; Angelique Biancotto; Melanie Merbah; Ivan Hirsch; Andrea Lisco; Jean Charles Grivel; Leonid Margolis
Journal:  PLoS One       Date:  2010-09-20       Impact factor: 3.240

5.  Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.

Authors:  Wendy Fitzgerald; Andrew W Sylwester; Jean-Charles Grivel; Jeffrey D Lifson; Leonid B Margolis
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Toxoplasma gondii inhibits R5 HIV-1 replication in human lymphoid tissues ex vivo.

Authors:  Atfa Sassi; Beda Brichacek; Sara Hieny; Felix Yarovinsky; Hana Golding; Jean-Charles Grivel; Alan Sher; Leonid Margolis
Journal:  Microbes Infect       Date:  2009-08-09       Impact factor: 2.700

7.  Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection.

Authors:  Marta Curriu; Jorge Carrillo; Marta Massanella; Elisabet Garcia; Francesc Cunyat; Ruth Peña; Peter Wienberg; Cristina Carrato; Joan Areal; Margarita Bofill; Bonaventura Clotet; Julià Blanco; Cecilia Cabrera
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.752

Review 8.  Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

Authors:  Jean-Charles Grivel; Robin J Shattock; Leonid B Margolis
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

9.  Replication of Epstein-Barr virus primary infection in human tonsil tissue explants.

Authors:  Kensei Gotoh; Yoshinori Ito; Seiji Maruo; Kenzo Takada; Terukazu Mizuno; Masaaki Teranishi; Seiichi Nakata; Tsutomu Nakashima; Seiko Iwata; Fumi Goshima; Shigeo Nakamura; Hiroshi Kimura
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

10.  Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs.

Authors:  Carolina Herrera; Mike D McRaven; Ken G Laing; Jayne Dennis; Thomas J Hope; Robin J Shattock
Journal:  Vaccines (Basel)       Date:  2021-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.